STRUCTURE THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Description as filed by funds: Election of the nominees for Class II director named below to hold office until the 2028 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Eric Dobmeier

STRUCTURE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Eric Dobmeier”): 133,703,367 for, 596,667 against, per its Form 8-K filed June 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 15,241,178 for, 86 against.

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Description as filed by funds: Election of the nominees for Class II director named below to hold office until the 2028 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Joanne Waldstreicher, M.D.

STRUCTURE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Joanne Waldstreicher, M.D.”): 131,397,750 for, 2,896,656 against, per its Form 8-K filed June 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 14,925,599 for, 315,665 against.

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Description as filed by funds: TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.

STRUCTURE THERAPEUTICS INC.’s own tally for this item (“Proposal 3: Advisory vote on the compensation of the Company's named executive officers On an advisory basis, the shareholders approved the compensation of the Company's named executive officers, as disclosed in the Comp”): 115,026,066 for, 19,231,338 against — passed, per its Form 8-K filed June 25, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3: Advisory vote on the compensation of the Company's named executive officers On an advisory basis, the shareholders approved the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual General Meeting.”
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 45 managers: 11,795,295 for, 3,445,969 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 124 managers: 34,027,827 for, 5,590,489 against, 34 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 44 managers: 15,211,531 1 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 115 managers: 1,182,051 for, 34 not voted, 38,197,554 1 year. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.

STRUCTURE THERAPEUTICS INC.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm”): 134,291,886 for, 27,066 against — passed, per its Form 8-K filed June 25, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm The Company's shareholders ratified the appointment by the Audit Committee of the Company's Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal …”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 15,241,264 for.

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.